FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.

More Latest News

FDA: Auvi-Q epinephrine injection recalled
October 30, 2015

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers. … Continue reading

FDA: US Compounding issues recall
October 29, 2015

This recall is due to the Food and Drug Administration concern over a lack of sterility assurance. Distributed nationwide to patients, providers, hospitals, and clinics Continue reading